French firm LNC has failed in its bid to gain an approved health claim for its medical weight loss drink Stablor, with EFSA critiquing one human clinical trial, and rejecting LNC’s other evidence.
from NutraIngredients RSS http://ift.tt/2lEqVoY
via IFTTT